05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
On December 16, 2019, the Mexican National Commission on Minimum Wages (Comisión Nacional de los Sal...
Read More >
Some interesting links we found across the web this week: 4 Tips for Managing Organizational Change...
Read More >
Pepper Hamilton partner Gregory J. Nowak hosted another virtual Investment Management and Private Fu...
Read More >
The end of the 2019 Texas legislative session, which ran until May 27, brings new challenges for emp...
Read More >
Since the start of the COVID-19 pandemic, several buyers in M&A transactions have sought to avoid cl...
Read More >
A recent decision by the Third District Court of Appeals has engendered uncertainty about the manner...
Read More >